Albert David, a company in the Pharmaceuticals industry, reported revenue of ₹101 crore and net profit of ₹2.88 crore for the September 2026 quarter.
Albert David (NSE: ALBERTDAVD) closed at ₹762.60 on 20 Nov 2026, down 4.8% over the past year. Its market capitalisation is ₹435 crore and it trades at 15.2 times earnings.
Incorporated in 1938, Albert David Ltd is in the business of manufacturing pharmaceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.